J P Kitzmann1, A R Pepper2, B Gala-Lopez2, R Pawlick2, T Kin2, D O'Gorman2, K R Mueller1, A C Gruessner1, E S Avgoustiniatos1, T Karatzas3, G L Szot4, A M Posselt4, P G Stock4, J R Wilson5, A M Shapiro2, K K Papas6. 1. Department of Surgery, University of Arizona, Tucson, Arizona, United States. 2. Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada. 3. Department of Surgery, University of Arizona, Tucson, Arizona, United States; Second Department of Propedeutic Surgery University of Athens, School of Medicine, Athens, Greece. 4. Diabetes Center, University of California, San Francisco, Calif, United States. 5. Wilson Wolf Manufacturing Corporation, New Brighton, Minn, United States. 6. Department of Surgery, University of Arizona, Tucson, Arizona, United States. Electronic address: kkpapas@surgery.arizona.edu.
Abstract
BACKGROUND: The shipment of human islets (IE) from processing centers to distant laboratories is beneficial for both research and clinical applications. The maintenance of islet viability and function in transit is critically important. Gas-permeable silicone rubber membrane (SRM) vessels reduce the risk of hypoxia-induced death or dysfunction during high-density islet culture or shipment. SRM vessels may offer additional advantages: they are cost-effective (fewer flasks, less labor needed), safer (lower contamination risk), and simpler (culture vessel can also be used for shipment). METHOD: IE were isolated from two manufacturing centers and shipped in 10-cm(2) surface area SRM vessels in temperature- and pressure-controlled containers to a distant center after at least 2 days of culture (n = 6). Three conditions were examined: low density (LD), high density (HD), and a microcentrifuge tube negative control (NC). LD was designed to mimic the standard culture density for IE preparations (200 IE/cm(2)), while HD was designed to have a 20-fold higher tissue density, which would enable the culture of an entire human isolation in 1-3 vessels. Upon receipt, islets were assessed for viability (measured by oxygen consumption rate normalized to DNA content [OCR/DNA)]), quantity (measured by DNA), and, when possible, potency and function (measured by dynamic glucose-stimulated insulin secretion measurements and transplants in immunodeficient B6 Rag(+/-) mice). Postshipment OCR/DNA was not reduced in HD vs LD and was substantially reduced in the NC condition. HD islets exhibited normal function postshipment. Based on the data, we conclude that entire islet isolations (up to 400,000 IE) may be shipped using a single, larger SRM vessel with no negative effect on viability and ex vivo and in vivo function.
BACKGROUND: The shipment of human islets (IE) from processing centers to distant laboratories is beneficial for both research and clinical applications. The maintenance of islet viability and function in transit is critically important. Gas-permeable silicone rubber membrane (SRM) vessels reduce the risk of hypoxia-induced death or dysfunction during high-density islet culture or shipment. SRM vessels may offer additional advantages: they are cost-effective (fewer flasks, less labor needed), safer (lower contamination risk), and simpler (culture vessel can also be used for shipment). METHOD: IE were isolated from two manufacturing centers and shipped in 10-cm(2) surface area SRM vessels in temperature- and pressure-controlled containers to a distant center after at least 2 days of culture (n = 6). Three conditions were examined: low density (LD), high density (HD), and a microcentrifuge tube negative control (NC). LD was designed to mimic the standard culture density for IE preparations (200 IE/cm(2)), while HD was designed to have a 20-fold higher tissue density, which would enable the culture of an entire human isolation in 1-3 vessels. Upon receipt, islets were assessed for viability (measured by oxygen consumption rate normalized to DNA content [OCR/DNA)]), quantity (measured by DNA), and, when possible, potency and function (measured by dynamic glucose-stimulated insulin secretion measurements and transplants in immunodeficient B6 Rag(+/-) mice). Postshipment OCR/DNA was not reduced in HD vs LD and was substantially reduced in the NC condition. HD islets exhibited normal function postshipment. Based on the data, we conclude that entire islet isolations (up to 400,000 IE) may be shipped using a single, larger SRM vessel with no negative effect on viability and ex vivo and in vivo function.
Authors: P R Rozak; B P Weegman; E S Avgoustiniatos; J R Wilson; D P Welch; B J Hering; K K Papas Journal: Transplant Proc Date: 2008-03 Impact factor: 1.066
Authors: E S Avgoustiniatos; B J Hering; P R Rozak; J R Wilson; L A Tempelman; A N Balamurugan; D P Welch; B P Weegman; T M Suszynski; K K Papas Journal: Transplant Proc Date: 2008-03 Impact factor: 1.066
Authors: A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey Journal: N Engl J Med Date: 2006-09-28 Impact factor: 91.245
Authors: Klearchos K Papas; Theodore Karatzas; Thierry Berney; Thomas Minor; Paris Pappas; François Pattou; James Shaw; Christian Toso; Henk-Jan Schuurman Journal: Clin Transplant Date: 2013-01-18 Impact factor: 2.863
Authors: H Ichii; Y Sakuma; A Pileggi; C Fraker; A Alvarez; J Montelongo; J Szust; A Khan; L Inverardi; B Naziruddin; M F Levy; G B Klintmalm; J A Goss; R Alejandro; C Ricordi Journal: Am J Transplant Date: 2007-04 Impact factor: 8.086
Authors: K K Papas; C K Colton; R A Nelson; P R Rozak; E S Avgoustiniatos; W E Scott; G M Wildey; A Pisania; G C Weir; B J Hering Journal: Am J Transplant Date: 2007-01-04 Impact factor: 8.086
Authors: Jonathan Weitz; Julia K Panzer; Mirza Muhammad Fahd Qadir; Silvia Álvarez-Cubela; Dagmar Klein; Yaisa Moreno-Hernández; Sirlene Cechin; Alejandro Tamayo; Joana Almaça; Helmut Hiller; Maria Beery; Irina Kusmartseva; Mark Atkinson; Stephan Speier; Camillo Ricordi; Alberto Pugliese; Alejandro Caicedo; Christopher A Fraker; Ricardo Luis Pastori; Juan Domínguez-Bendala Journal: Nat Commun Date: 2020-06-29 Impact factor: 14.919
Authors: Darling M Rojas-Canales; Michaela Waibel; Aurelien Forget; Daniella Penko; Jodie Nitschke; Fran J Harding; Bahman Delalat; Anton Blencowe; Thomas Loudovaris; Shane T Grey; Helen E Thomas; Thomas W H Kay; Chris J Drogemuller; Nicolas H Voelcker; Patrick T Coates Journal: Endocr Connect Date: 2018-02-26 Impact factor: 3.335